Dr. Laura Jelliffe-Pawlowski is a Professor of Epidemiology & Biostatistics in the UCSF School of Medicine and is the Director of Precision Health and Discovery with the UCSF California Preterm Birth Initiative (pretermbirthca.ucsf.edu). She serves as the Primary Investigator for the HOPE COVID-19 study which examines the impact of COVID-19 and pandemic-related hardship on adverse pregnancy and infant outcomes (HOPE.UCSF.edu/covid_19). She is also a leader and founder of the HOPE Consortium (HOPE.UCSF.edu) which includes investigators from across the US and world whose work focuses on uncovering causes of adverse pregnancy and infant outcomes and identifying in-roads for interventions. Dr. Jelliffe-Pawlowski is also a Primary Investigator on the PROMPT study which looks at metabolic predictors of newborn maturity, mortality, and morbidity and includes US and global efforts focused on uncovering in-roads to predict outcomes and prevent sickness and disability. She has served as a state, national, and international adviser on committees and task forces focused on the early detection and prevention of preterm birth and developmental disabilities and holds patents for blood tests and algorithms predicting preterm birth.